{"id":"https://genegraph.clinicalgenome.org/r/46da8887-0654-41c6-913e-8267f45b3c76v1.0","type":"EvidenceStrengthAssertion","dc:description":"*MTX2* was first reported in relation to autosomal recessive  mandibuloacral dysplasia progeroid syndrome (MDPS; OMIM # 619127) in 2020 (Elouej et al., PMID: 32917887).  MDPS is a severe laminopathy-like disorder characterized by by dysmorphic facial features, lipodystrophy, skin changes, clavicular hypoplasia, acral osteolysis, and normal intelligence with an unknown prevalence. *MTX2* encodes the metaxin 2 protein which is located at the outer mitochondrial membrane (OMM) and faces the cytosolic compartment through direct interaction with its partner Metaxin-1 (MTX1). It is involved in protein translocation into mitochondria.\n\nEvidence supporting this gene-disease relationship includes case-level data, segregation data and experimental data. Nine unique loss of function variants (frameshift, start loss, splice variants) that have been reported in 8 probands in 3 publications are included in this curation  (PMID: 32917887; Dogan et al 2022, PMID: 36269149; Li et al 2024, PMID: 38250156). \nThe mechanism of pathogenicity appears to be loss of function. This gene-disease relationshipis also supported by expression studies, t animal models, rescue experiments, and in-vitro functional assays. Experimentally, *MTX2* deficiency is demostrated to result in loss of Metaxin-1 (MTX1) and mitochondrial dysfunction, including network fragmentation and oxidative phosphorylation impairment, which may account for poor growth, hypotonia, muscle weakness, skeletal abnormalities, nephrotic proteinuria and glomerulopathy.\n\nIn summary, there is definitive evidence supporting the relationship between *MTX2* and  autosomal recessive mandibuloacral dysplasia progeroid syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the Syndromic Disorders GCEP on the meeting date June 5, 2024 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/46da8887-0654-41c6-913e-8267f45b3c76","GCISnapshot":"https://genegraph.clinicalgenome.org/r/95b2738d-c934-401b-8665-dd6a19ec6a05","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/95b2738d-c934-401b-8665-dd6a19ec6a05_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-09-26T15:04:19.741Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/95b2738d-c934-401b-8665-dd6a19ec6a05_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-06-05T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95b2738d-c934-401b-8665-dd6a19ec6a05_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa2b87e1-ad77-4513-b95b-cf304fbd3c03_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3384b11b-de0e-47b3-85a6-b31df9055f20","type":"EvidenceLine","dc:description":"1.5 +1.5= 3-1= 2\n","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3384b11b-de0e-47b3-85a6-b31df9055f20_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","allele":{"id":"https://genegraph.clinicalgenome.org/r/c51a1ea1-0952-4581-9515-024ef78c5c48","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006554.5(MTX2):c.2T>A (p.Met1Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349365981"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/aa2b87e1-ad77-4513-b95b-cf304fbd3c03","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","rdfs:label":"Elouej_MADM1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":24,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c51a1ea1-0952-4581-9515-024ef78c5c48"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000348","obo:HP_0009771","obo:HP_0009064","obo:HP_0002240","obo:HP_0005328","obo:HP_0100679","obo:HP_0000097","obo:HP_0000322","obo:HP_0001712","obo:HP_0008070","obo:HP_0001655","obo:HP_0000093","obo:HP_0010284","obo:HP_0001371","obo:HP_0001403","obo:HP_0001290","obo:HP_0000347","obo:HP_0001387","obo:HP_0000160","obo:HP_0000678","obo:HP_0000218","obo:HP_0000938","obo:HP_0008404","obo:HP_0002857","obo:HP_0002910"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3384b11b-de0e-47b3-85a6-b31df9055f20_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/d5c6cf00-0231-4428-8a70-62b0df15fb50_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6275520c-669b-4108-bb30-58bb69e1462e","type":"EvidenceLine","dc:description":"(1.5 +1.5)= 3-1=2\n","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6275520c-669b-4108-bb30-58bb69e1462e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","allele":{"id":"https://genegraph.clinicalgenome.org/r/d5aebb63-78ae-4278-b394-5a540b4f7c9e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006554.5(MTX2):c.603del (p.Tyr202IlefsTer26)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915942215"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/d5c6cf00-0231-4428-8a70-62b0df15fb50","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","rdfs:label":"Elouej_MADM4-2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d5aebb63-78ae-4278-b394-5a540b4f7c9e"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Sparse hypopigmented hair, sparse eyebrows, delayed closure of cranial sutures, mitral regurgitation, left ventricular hypertrophy, hepatomegaly\n","phenotypes":["obo:HP_0002240","obo:HP_0000968","obo:HP_0008070","obo:HP_0002910","obo:HP_0000348","obo:HP_0000343","obo:HP_0001712","obo:HP_0008404","obo:HP_0006254","obo:HP_0011040","obo:HP_0001653","obo:HP_0000414","obo:HP_0000668","obo:HP_0005458","obo:HP_0005328","obo:HP_0005280","obo:HP_0001397","obo:HP_0000347","obo:HP_0000160","obo:HP_0000490"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6275520c-669b-4108-bb30-58bb69e1462e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/093099ff-b34f-41f8-a78e-7ad3f9d33c80_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dfd122d2-a0f6-493e-8f7a-521fe3ac7cef","type":"EvidenceLine","dc:description":"(1.5 +1.5)= 3-1 = 2\n","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dfd122d2-a0f6-493e-8f7a-521fe3ac7cef_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"To confirm the pathogenicity of MTX2 mutations, functional in vitro studies were performed on cutaneous primary fibroblasts from patient: MADM3. cDNA sequence analysis showed a deletion of the entire exon 4 for patient MADM3 (c.136_208del), leading to premature termination codons p.Ala46Valfs*12.\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/dfd122d2-a0f6-493e-8f7a-521fe3ac7cef_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","allele":{"id":"https://genegraph.clinicalgenome.org/r/535bc8df-0250-4cd3-a133-4aee64914a29","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006554.5(MTX2):c.208+3_208+6del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915942214"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/093099ff-b34f-41f8-a78e-7ad3f9d33c80","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","rdfs:label":"Elouej_MADM3","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":24,"allele":{"id":"https://genegraph.clinicalgenome.org/r/535bc8df-0250-4cd3-a133-4aee64914a29"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001653","obo:HP_0000093","obo:HP_0009064","obo:HP_0001387","obo:HP_0001290","obo:HP_0000938","obo:HP_0001371","obo:HP_0008404","obo:HP_0008070","obo:HP_0000347","obo:HP_0000160","obo:HP_0002240","obo:HP_0001712","obo:HP_0000097","obo:HP_0004382","obo:HP_0000678"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/dfd122d2-a0f6-493e-8f7a-521fe3ac7cef_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4e885720-02b7-45d5-ae76-1226e9e4b10f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/caf3ab67-783c-4817-bef7-7233fd9f4921","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/caf3ab67-783c-4817-bef7-7233fd9f4921_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38250156","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce4104dc-f459-4c34-9b48-fe24cd8c67e3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006554.5(MTX2):c.378+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349698062"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1bb61756-1a60-4c5f-bae5-4919b2ec696d","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bb61756-1a60-4c5f-bae5-4919b2ec696d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38250156","allele":{"id":"https://genegraph.clinicalgenome.org/r/a9174f52-1b80-483b-8a6a-9782864ca1d4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006554.5(MTX2):c.97del (p.Ile33PhefsTer25)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA761100973"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4e885720-02b7-45d5-ae76-1226e9e4b10f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38250156","rdfs:label":"Li_patient 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":23,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/ce4104dc-f459-4c34-9b48-fe24cd8c67e3"},{"id":"https://genegraph.clinicalgenome.org/r/a9174f52-1b80-483b-8a6a-9782864ca1d4"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0006829","obo:HP_0000822","obo:HP_0008897","obo:HP_0000282","obo:HP_0002371","obo:HP_0000093","obo:HP_0002090","obo:HP_0003698"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/1bb61756-1a60-4c5f-bae5-4919b2ec696d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/caf3ab67-783c-4817-bef7-7233fd9f4921_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/38303519-85e4-4534-addb-15215d045a05_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5efea302-fd78-4d3e-9635-e769c4467829","type":"EvidenceLine","dc:description":"(0.5 +0.5) = 1-0.5 = 0.5","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5efea302-fd78-4d3e-9635-e769c4467829_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36269149","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a439d3a-8eb3-4724-b36b-fac9fc1e8164","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006554.5(MTX2):c.543+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349698814"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/38303519-85e4-4534-addb-15215d045a05","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36269149","rdfs:label":"Dogan-case report","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5a439d3a-8eb3-4724-b36b-fac9fc1e8164"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000430","obo:HP_0000670","obo:HP_0001363","obo:HP_0200021","obo:HP_0000418","obo:HP_0004322","obo:HP_0001744","obo:HP_0008812","obo:HP_0000160","obo:HP_0000938","obo:HP_0000093","obo:HP_0001620","obo:HP_0000520","obo:HP_0000337","obo:HP_0000347","obo:HP_0002240","obo:HP_0000293","obo:HP_0009064","obo:HP_0002208","obo:HP_0002652","obo:HP_0030055","obo:HP_0002761","obo:HP_0004443","obo:HP_0001644"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5efea302-fd78-4d3e-9635-e769c4467829_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/1b60efc5-bdfc-4733-aa7a-a9c50df56132_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8068a17c-6753-4256-8e54-885ce0455260","type":"EvidenceLine","dc:description":"( 1.5 +1.5) =3-1 =2\n","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8068a17c-6753-4256-8e54-885ce0455260_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","allele":{"id":"https://genegraph.clinicalgenome.org/r/e696c87d-1740-40e0-824e-3cfaabe11d5d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006554.5(MTX2):c.295_296del (p.Leu99Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1979058"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/1b60efc5-bdfc-4733-aa7a-a9c50df56132","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","rdfs:label":"Elouej_MADM5","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":17,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e696c87d-1740-40e0-824e-3cfaabe11d5d"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"mandibular hypoplasia, joint contractures, sparse hair, generalized lipodystrophy, hypopigmentation,","phenotypes":["obo:HP_0008070","obo:HP_0001655","obo:HP_0000668","obo:HP_0009064","obo:HP_0010940","obo:HP_0000325","obo:HP_0000160","obo:HP_0005328","obo:HP_0002240","obo:HP_0000968","obo:HP_0002164","obo:HP_0002828","obo:HP_0000490","obo:HP_0008404","obo:HP_0001010","obo:HP_0000414","obo:HP_0000369","obo:HP_0010648","obo:HP_0001090","obo:HP_0000322","obo:HP_0010575","obo:HP_0000347","obo:HP_0002007"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8068a17c-6753-4256-8e54-885ce0455260_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/98d90b28-dc58-481e-ba43-9a4ff1512830_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba1a26a2-ed33-477d-8725-9b91c3d46ba3","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba1a26a2-ed33-477d-8725-9b91c3d46ba3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"To confirm the pathogenicity of MTX2 mutations, functional in vitro studies were performed on cutaneous primary fibroblasts from patients MADM2. cDNA sequence analysis showed a deletion of 7 basepair at the beginning of exon 9 for patient MADM2 (c.544_550del) leading to premature termination codons respectively p.Val182Argfs*3. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ba1a26a2-ed33-477d-8725-9b91c3d46ba3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","allele":{"id":"https://genegraph.clinicalgenome.org/r/abf116f5-3cc9-4026-bc4e-b982f6a6cd1b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006554.5(MTX2):c.544-1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349698996"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/98d90b28-dc58-481e-ba43-9a4ff1512830","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","rdfs:label":"Elouej_MADM2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":24,"allele":{"id":"https://genegraph.clinicalgenome.org/r/abf116f5-3cc9-4026-bc4e-b982f6a6cd1b"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000097","obo:HP_0000160","obo:HP_0000347","obo:HP_0002155","obo:HP_0008070","obo:HP_0008897","obo:HP_0001655","obo:HP_0009125","obo:HP_0008404","obo:HP_0034392","obo:HP_0001403","obo:HP_0001397","obo:HP_0000938","obo:HP_0000678","obo:HP_0010284","obo:HP_0000093","obo:HP_0001371","obo:HP_0000348","obo:HP_0100679","obo:HP_0009064","obo:HP_0002857","obo:HP_0002240","obo:HP_0000218","obo:HP_0000939","obo:HP_0001387","obo:HP_0001290","obo:HP_0001653"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ba1a26a2-ed33-477d-8725-9b91c3d46ba3_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/95b2738d-c934-401b-8665-dd6a19ec6a05_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95b2738d-c934-401b-8665-dd6a19ec6a05_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bfd14489-1461-4c09-a9a4-da304e2835ec","type":"EvidenceLine","dc:description":"model organism","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7fd4c88-e9f2-4f5b-a097-c65c5d552e30","type":"Finding","dc:description":"mtx-2 knock-out in C. elegans showed nuclear and mitochondrial morphological abnormalities.  \nmtx-2 downregulation was obtained in C. elegans using both mtx-2 RNAi in a strain-expressing lmn-1:gfp(Ce-lamin-GFP) and mtx-2 KO in a strain expressing a mitochondrial matrix-targeted GFP in body-wall muscle cells (mitogfp). \n\nfrom the text: \"mtx-2 downregulation by siRNA led to nuclear morphological abnormalities together with Ce-lamin-GFP nuclear aggregates that increased with the worm’s age (Fig. 5g–h), similar to previous\nresults on patients’ cells\"\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","rdfs:label":"MTX2 Knock-out","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/bb389462-fbbd-4860-af46-e3f952f7f400","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ac97dc3-c718-4d21-8ae4-28b31b2ebe44","type":"Finding","dc:description":"Mitochondrial network analysis using the MINA toolset on healthy and MADM2 and MADM3 patients’ fibroblasts before and after MTX2-cDNA transfection showing improved mitochondrial footprint, individuals, networks, and branches per network for all parameters in PT conditions, when compared either to the patient’s nontransfected cells or to control cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","rdfs:label":"Wild-type MTX2-cDNA transfection restores disease phenotypes","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/95b2738d-c934-401b-8665-dd6a19ec6a05_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ec1b4e3-f113-429d-be30-392c4bc16de6","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4e30b19-1e52-49ab-bed2-1ed2d2e6060a","type":"FunctionalAlteration","dc:description":"The number of dead cells upon apoptosis was significantly reduced in patients compared to control fibroblasts, confirmed by the reduction of Caspase 3 cleavage in MTX2-mutant fibroblasts.\nObserved Increased macro-autophagy in MTX2 deficient patient fibroblast cells. \nThe mitochondrial dysfunction and hampered apoptosis may account for the lipodystrophy and progeroid like features, hepatomegaly\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","rdfs:label":"MTX2 and MTX1 deficiency hampers TNF-α-induced apoptosis"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/29b3cd55-f0fc-4455-a977-21ecf0470c34","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec866331-c36c-4b50-8163-8ba5f2cb30e4","type":"FunctionalAlteration","dc:description":"Immunoblot analysis of MTX2 and other outer mitochondrial membrane proteins of whole-cell extracts from healthy control (WT) and patients’ (MADM2, MADM3) fibroblasts shows that MTX2 deficiency leads to loss of Metaxin-1 (MTX1) and mitochondrial dysfunction, including network fragmentation and oxidative phosphorylation impairment. May account for Poor growth, hypotonia, muscle weakness, skeletal abnormalities, nephrotic proteinuria and glomerulopathy","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32917887","rdfs:label":"Immunoblot analysis of MTX2"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Definitive","sequence":9043,"specifiedBy":"GeneValidityCriteria10","strengthScore":16.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/XSseefNd6yg","type":"GeneValidityProposition","disease":"obo:MONDO_0030880","gene":"hgnc:7506","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_95b2738d-c934-401b-8665-dd6a19ec6a05-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}